Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers

被引:90
作者
Zhang, J
Scordi, I
Smyth, MJ
Lichtenheld, MG
机构
[1] Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA
[2] Austin Hosp, Austin Res Inst, Cellular Cytotoxic Lab, Heidelberg, Vic 3084, Australia
关键词
cytotoxic T lymphocyte; IL-2; receptor; T cell activation; perforin; transgenic mouse;
D O I
10.1084/jem.190.9.1297
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Optimal T cell differentiation into effector cells with specialized functions requires the participation of cytokine receptor signals. In T helper cells, this process is controlled by chromatin changes and distal and proximal regulatory elements as well as specific transcription factors. Analogous events during cytotoxic T lymphocyte (CTL) differentiation remain to be identified. This process is known, however, to be crucially regulated by interleukin (IL)-2 receptor (R) signals. It is accompanied by the induction of perforin expression via a mechanism that does not entail proximal regulatory elements. In this report, transgenically expressed human perforin gene locus DNAs demonstrate that IL-2R signals target two IL-a-dependent enhancers similar to 15 and 1 kilobase upstream of the promoter. The most distal enhancer may also respond to TCR signals. In transient transfections, both enhancers required two identically spaced Stat-like elements for their activation, which was abolished by expression of a dominant negative signal transducer and activator of transcription (Stat)5 molecule, whereas a constitutively active Stat5 molecule bypassed the requirement for IL-2R signals. These results provide a molecular explanation for the activation of the perforin gene during CTL differentiation and complement the analysis of animals deficient in the activation of the IL-2R Stat signaling pathway by establishing perforin as a target gene.
引用
收藏
页码:1297 / 1307
页数:11
相关论文
共 63 条
[1]   Defective IL-2-mediated IL-2 receptor α chain expression in Stat3-deficient T lymphocytes [J].
Akaishi, H ;
Takeda, K ;
Kaisho, T ;
Shineha, R ;
Satomi, S ;
Takeda, J ;
Akira, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (11) :1747-1751
[2]  
ARIMA N, 1992, J IMMUNOL, V149, P83
[3]   Cytokine receptor-independent, constitutively active variants of STAT5 [J].
Berchtold, S ;
Moriggl, R ;
Gouilleux, F ;
Silvennoinen, O ;
Beisenherz, C ;
Pfitzner, E ;
Wissler, M ;
Stocklin, E ;
Groner, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30237-30243
[4]  
Bright JJ, 1997, J IMMUNOL, V159, P175
[5]   Potent inhibition of CTLA-4 expression by an anti-CTLA-4 ribozyme [J].
Cepero, E ;
Hnatyszyn, HJ ;
Kraus, G ;
Lichtenheld, MG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (03) :838-843
[6]   HYBRIDS BETWEEN RAT LYMPHOMA AND MOUSE T-CELLS WITH INDUCIBLE CYTOLYTIC ACTIVITY [J].
CONZELMANN, A ;
CORTHESY, P ;
CIANFRIGLIA, M ;
SILVA, A ;
NABHOLZ, M .
NATURE, 1982, 298 (5870) :170-172
[7]   CYTOLYSIS BY H-2-SPECIFIC-T KILLER CELLS - ASSEMBLY OF TUBULAR COMPLEXES ON TARGET MEMBRANES [J].
DENNERT, G ;
PODACK, ER .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (05) :1483-1495
[8]   A T cell-specific enhancer in the interleukin-3 locus is activated cooperatively by Oct and NFAT elements within a DNase I-hypersensitive site [J].
Duncliffe, KN ;
Bert, AG ;
Vadas, MA ;
Cockerill, PN .
IMMUNITY, 1997, 6 (02) :175-185
[9]  
FEUERSTEIN N, 1995, J IMMUNOL, V154, P68
[10]   Functional dissection of the cytoplasmic subregions of the IL-2 receptor βc chain in primary lymphocyte populations [J].
Fujii, H ;
Ogasawara, K ;
Otsuka, H ;
Suzuki, M ;
Yamamura, K ;
Yokochi, T ;
Miyazaki, T ;
Suzuki, H ;
Mak, TW ;
Taki, S ;
Taniguchi, T .
EMBO JOURNAL, 1998, 17 (22) :6551-6557